TS Financial Group (TSFG)’s Xeris Biopharma Holdings XERS Stock Holding History

TS Financial Group (TSFG)’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4K	Hold	708	–	–	﹤0.01%	702
2025 Q4	$6K	Sell	708 -350	-33%	-$2.75K	﹤0.01%	648
2025 Q3	$9K	Hold	1,058	–	–	﹤0.01%	596
2025 Q2	$5K	Hold	1,058	–	–	﹤0.01%	649
2025 Q1	$6K	Buy	1,058 +350	+49%	+$1.41K	﹤0.01%	602
2024 Q4	$2K	Hold	708	–	–	﹤0.01%	680
2024 Q3	$2K	Hold	708	–	–	﹤0.01%	708
2024 Q2	$2K	Hold	708	–	–	﹤0.01%	697
2024 Q1	$2K	Buy	+708	New	+$1.83K	﹤0.01%	692
2023 Q2	–	Sell	-5,488	Closed	-$9K	–	1072
2023 Q1	$9K	Hold	5,488	–	–	﹤0.01%	554
2022 Q4	$7K	Hold	5,488	–	–	﹤0.01%	597
2022 Q3	$9K	Hold	5,488	–	–	﹤0.01%	543
2022 Q2	$8K	Buy	+5,488	New	+$11.6K	﹤0.01%	584
2022 Q1	–	Sell	-5,488	Closed	-$16K	–	1025
2021 Q4	$16K	Buy	+5,488	New	+$11.9K	0.01%	478

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TS Financial Group (TSFG)'s XERS Position: Q1 2026 in Review

TS Financial Group (TSFG) held its Xeris Biopharma Holdings (XERS) position steady in Q1 2026 at 708 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #702.

TS Financial Group (TSFG) first reported a position in XERS in Q4 2021 and has held it in 14 quarters since. The position peaked at $16K in Q4 2021. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

TS Financial Group (TSFG) held 708 shares of Xeris Biopharma Holdings worth $4K as of Q1 2026.
TS Financial Group (TSFG) left its Xeris Biopharma Holdings share count unchanged in Q1 2026.
Xeris Biopharma Holdings made up ﹤0.01% of TS Financial Group (TSFG)'s portfolio in Q1 2026, its #702 holding.
TS Financial Group (TSFG) first reported a position in Xeris Biopharma Holdings in Q4 2021 and has held it in 14 quarters since.
TS Financial Group (TSFG)'s Xeris Biopharma Holdings position peaked at $16K in Q4 2021.
237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q1 2026, filed 27 Apr 2026.